-
389NewsFocused on positive impact: Ricola becomes a B Corporation
LAUFEN, SWITZERLAND – Newsaktuell – 4 March 2024 – Marking an important milestone on its sustainability journey, Ricola is now a certified...
-
329NewsBerlin Cures’ BC 007 Targeting Long COVID Achieves Solid Progress with Over 50% Patient Recruitment in Phase II Trial
Berlin Cures, a clinical-stage biotechnology firm, advances innovative treatment aimed at combating Long COVID, currently impacting over 100 million people globally. Over...
-
404Wire StoriesSea Limited Reports Fourth Quarter and Full Year 2023 Results
SINGAPORE–(BUSINESS WIRE)–Sea Limited (NYSE: SE) (“Sea” or the “Company”) today announced its financial results for the fourth quarter and full year ended...
-
358Wire StoriesPower Restored After Interruption at CSA Copper Mine
ST. HELIER, Jersey–(BUSINESS WIRE)–Metals Acquisition Limited ARBN 671 963 198 (NYSE: MTAL; ASX: MAC) Metals Acquisition Limited ARBN 671 963 198 (NYSE:...
-
325Wire StoriesKao the Sole Japanese and Asian Company Included in the World’s Most Ethical Companies® List for a Record 18th Consecutive Year
TOKYO–(BUSINESS WIRE)–#ESG–The Ethisphere Institute, a leading US think-tank, has named Kao Corporation (TOKYO:4452) one of the World’s Most Ethical Companies. Kao is...
-
460NewsHeng An Standard Life (Asia) fully supports Hong Kong new Capital Investment Entrant Scheme with ILAS now available for application
Celebrating our 25 years by introducing the “5N Proposition” to provide customers with comprehensive long-term insurance and wealth management services HONG KONG...
-
288Wire StoriesHytera Unveils Wearable Two-Way Radio and S Series Product Line
SHENZHEN, China–(BUSINESS WIRE)–#Hytera–Hytera Communications (SZSE: 002583), a leading global provider of professional communications technologies and solutions, proudly introduces its latest innovation: the...
-
417NewsHPV Affects Us All – Be Protected and Make It #OneLessWorry
KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 4 March 2024 – Human papillomavirus (HPV) is the primary cause of cervical cancer....
-
317NewsBerlin Cures’ BC 007 Targets Long COVID: Solid Phase II Trial Progress with Over 50% Patient Recruitment
Berlin Cures, a clinical-stage biotechnology firm, advances innovative treatment aimed at combating Long COVID, currently impacting over 100 million people globally. Over...
-
389News
AIM Vaccine Enters the Period of Explosive Growth in Major Single Products
Leading the Two Golden Tracks of Pneumonia Vaccine and Rabies Vaccines HONG KONG SAR – Media OutReach Newswire – 4 March 2024...
